AzTrials
AzTrials

ARTNCT04546412

Importance of the Microtubule Cytoskeleton in Oocyte Competence

An observational study of ART, run by Instituto Valenciano de Infertilidade de Lisboa at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will assess if there are microtubule cytoplasmic features specifically associated with oocyte vitrification. Read more about this study

Who is it for?
Ages 18 to 34 years, women onlyHealthy volunteers can take part
Conditions the study is for
ART
What is being tested?
Vitrification and thawing
Type of treatment
Medical device
How many people
6 participants
Where
1 sitePortugal
Study dates
9 Oct 2020to 12 Oct 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 34 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Healthy women who have consented to a cycle of fresh oocyte donation and who have a total antral-follicle count (AFC) above 20 at the onset of ovarian stimulation.

Who may be able to join

  • Informed consent form dated and signed.
  • Already consented to perform oocyte donation.
  • Age ≥18 and <35 years old.
  • AFC ≥20.
  • BMI ≥18.5 Kg/m2 and <30 Kg/m2.
  • Two ovaries present.
  • No current pregnancy-wish.

Who cannot join

  • Simultaneous participation in another clinical study or participation in another clinical study before inclusion in the present study that could affect its objectives.
  • Previous history of poor ovarian response (<4 oocytes retrieved) with a maximal dose of ovarian stimulation (≥300 IU/day).
  • Use of hormone contraceptives in the month preceding eventual inclusion.
  • Presence of a medical condition which is known to affect ART outcome (e.g. thyroid dysfunction).
  • Active female smoking.
  • Ongoing pregnancy.
  • Current use of anti-depressants, anti-psychotics, steroids, antiepileptics or chemotherapy.
  • Known allergy or hypersensitivity to any of the study non-IMP.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Instituto Valenciano de Infertilidade

    Lisbon

Other trials in Portugal

About this study

This study will assess if there are microtubule cytoplasmic features specifically associated with oocyte vitrification.

Read the detailed description

Successful fertilization is heavily dependent upon inherent qualities of the oocytes, and thus reliant upon the fidelity of oocyte maturation. Reduced oocyte developmental competence is one of the main reasons for the decreased potential of in-vitro-produced embryos. Approximately 8,6% to 15% of all infertility patients produce at least one meiotically incompetent oocyte. There are also extreme cases of women which generate oocytes with complete or predominant failure to complete meiosis. These oocytes arrest and do not complete meiosis in response to exogenous final maturation and ovulation triggering. The incidence of this is unknown, and given the complexity of the processes involved in oocyte maturation, it has been difficult to define the key events or morphological features underlying oocyte competence.

An increasing amount of evidence in the past years has suggested that the microtubule (MT) cytoskeleton may have an important role in providing the oocyte with competence potential. Oocyte maturation involves major rearrangements of the MT cytoskeleton. It is well known the importance of forming a proper microtubule meiotic spindle for chromosome segregation upon meiosis. Moreover, MTs seem to be important for the redistribution of different organelles upon maturation. However, the exact functional significance of this reorganization and how MTs influence competence through the repositioning of these organelles is largely unknown.

The main MT organizing center in eukaryotic cells is the centrosome. Indeed, centrosomes are essential for the formation of the mitotic MT bipolar spindle. Interestingly, in the vast majority of female eggs these structures are eliminated, and the meiotic spindle does not contain centrosomes. A recent study in the lab organism Drosophila melanogaster (fruit fly), showed that interrupting this elimination, forcing the maintenance of centrosomes up to meiosis, led to female infertility. Both meiosis and the first nuclear divisions upon fertilization showed abnormal MT spindles with abnormal chromosome congression. This shows that proper spaciotemporal MT organization is likely to have important implications on oocyte competence.

The long-term goal of this research group is to analyze the MT cytoskeleton of oocytes from women which, upon assisted reproductive technologies, generate a high percentage of arrested embryos. In order to do this, the MT features of already-available surplus and unused oocytes which are vitrified and available for research purposes will be compared. These oocytes were donated from cycles in which a low (<20% the fertilized embryos) and high (>20% the fertilized embryos) incidence of arrested embryos was seen. Previous studies have posited that oocyte vitrification and warming may expose the oocyte to a variety of physical and chemical processes which may impact on their structural and genomic integrity. Therefore, this initial feasibility pilot study will investigate potential structural consequences for the oocytes of the vitrification procedure used in house.

Thus, it will be assess whether the Cryotop® - Open System induces specific MT features which may be absent in fresh oocytes. In case that both fresh and vitrified oocytes (derived from the same patient - sibling oocytes study) show a similar MT cytoskeleton organization, a collection of cryopreserved oocytes donated for research purposes will be used in the planned future studies of this research group.

Conditions
ART
Being tested
Vitrification and thawing
Keywords
Oocyte competence, Oocyte vitrification, Cryobiology, Microtubule cytoskeleton

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitrification and thawingDevice

    Vitrification using the Cryotop® - Open System followed by thawing

Study groups in NCT04546412
Study groupRoleWhat they receive
Fresh oocytesSibling oocytes not subjected to vitrification prior to assessment
Vitrified-thawed oocytesSibling oocytes subjected to vitrification using the Cryotop® - Open System and thawing prior to assessment
Receives: Device: Vitrification and thawing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ocurrence of diferent features in the microtubule cytoskeleton

    Both fresh and vitrified-warmed oocytes will be analysed in respect to: spindle morphology; chromosome congression at the metáfase plate; presence of microtubule aggregates and presence of pericentriolar material aggregates.

    Measured: From October 2020 up to December 2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2020
  2. Study start9 Oct 2020
  3. Primary completion12 Oct 2021
  4. Study completion12 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04546412
Sponsor's protocol ID
1907-LIS-072-AP
Status last verified
Aug 2022
First submitted
8 Sep 2020
Last updated
4 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of ART, run by Instituto Valenciano de Infertilidade de Lisboa at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ocurrence of diferent features in the microtubule cytoskeleton (time frame: From October 2020 up to December 2020). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in